Israeli MedTech Company Restore Medical Secures USD 23M
Israeli medtech startup Restore Medical Ltd. has raised USD 23 million in a Series B financing round to advance its catheter-based device for treating heart failure with reduced ejection fraction (HFrEF), a condition with few effective interventional options.
The round was co-led by Pitango HealthTech and a global strategic healthcare investor, with continued support from Peregrine Ventures and the European Innovation Council (EIC) Fund.
The July 2025 closing marks a major step in Restore Medical’s mission to transform heart failure treatment. Founded in Israel, the company focuses on minimally invasive cardiovascular technologies.
Arnon, Tadmor-Levy advised Restore Medical on the transaction. The team was led by Elie Sprung and Shir Savyon, who have represented the company since 2016.
